Global Peptide Therapeutics Market Size study, By Route of Administration (Parenteral Route, Oral Route, Pulmonary, Mucosal, Others), By Type (Generic, Innovative), By Application (Cancer, Cardiovascular Diseases, Central Nervous Systems, Infections, Respiratory Disorders, Other Applications), and Regional Forecasts 2022-2028
- BIZ4982968
- 200 Pages
- June 2022
- Pharmaceuticals
The key regions considered for the global Peptide Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growth of the biotechnology industry and rising focus on the introduction of novel drugs. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing investments in research and development activities, and the rising incidences of cancer, would create lucrative growth prospects for the Peptide Therapeutics Market across the Asia-Pacific region.
Major market players included in this report are:
Eli Lilly and Company
Pfizer, Inc.
Amgen, Inc.
Takeda Pharmaceutical Company Limited
Teva Pharmaceuticals Industries Ltd.
Lonza Inc.
Sanofi
Bristol-Myers Squibb (BMS)
AstraZeneca PLC
Novartis AG
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Route of Administration:
Parenteral Route
Oral Route
Pulmonary
Mucosal
Others
By Type:
Generic
Innovative
By Application:
Cancer
Cardiovascular Diseases
Central Nervous Systems
Infections
Respiratory Disorders
Other Applications
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Peptide Therapeutics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Peptide Therapeutics Market, by Region, 2020-2028 (USD Million)
1.2.2. Peptide Therapeutics Market, by Route of Administration, 2020-2028 (USD Million)
1.2.3. Peptide Therapeutics Market, by Type, 2020-2028 (USD Million)
1.2.4. Peptide Therapeutics Market, by Application, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Peptide Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Peptide Therapeutics Market Dynamics
3.1. Peptide Therapeutics Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing incidences of cancer and metabolic disorder
3.1.1.2. Introduction of novel drugs
3.1.2. Market Challenges
3.1.2.1. Imposition of stringent regulations for drug approval
3.1.2.2. High cost of developing drugs
3.1.3. Market Opportunities
3.1.3.1. Rising research and development activities
3.1.3.2. Technological advancements
Chapter 4. Global Peptide Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Peptide Therapeutics Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Peptide Therapeutics Market by Route of Administration, Performance – Potential Analysis
6.3. Global Peptide Therapeutics Market Estimates & Forecasts by Route of Administration, 2018-2028 (USD Million)
6.4. Peptide Therapeutics Market, Sub Segment Analysis
6.4.1. Parenteral Route
6.4.2. Oral Route
6.4.3. Pulmonary
6.4.4. Mucosal
6.4.5. Others
Chapter 7. Global Peptide Therapeutics Market, by Type
7.1. Market Snapshot
7.2. Global Peptide Therapeutics Market by Type, Performance - Potential Analysis
7.3. Global Peptide Therapeutics Market Estimates & Forecasts by Type, 2018-2028 (USD Million)
7.4. Peptide Therapeutics Market, Sub Segment Analysis
7.4.1. Generic
7.4.2. Innovative
Chapter 8. Global Peptide Therapeutics Market, by Application
8.1. Market Snapshot
8.2. Global Peptide Therapeutics Market by Application, Performance - Potential Analysis
8.3. Global Peptide Therapeutics Market Estimates & Forecasts by Application, 2018-2028 (USD Million)
8.4. Peptide Therapeutics Market, Sub Segment Analysis
8.4.1. Cancer
8.4.2. Cardiovascular Diseases
8.4.3. Central Nervous Systems
8.4.4. Infections
8.4.5. Respiratory Disorders
8.4.6. Other Applications
Chapter 9. Global Peptide Therapeutics Market, Regional Analysis
9.1. Peptide Therapeutics Market, Regional Market Snapshot
9.2. North America Peptide Therapeutics Market
9.2.1. U.S. Peptide Therapeutics Market
9.2.1.1. Route of Administration breakdown estimates & forecasts, 2018-2028
9.2.1.2. Type breakdown estimates & forecasts, 2018-2028
9.2.1.3. Application breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Peptide Therapeutics Market
9.3. Europe Peptide Therapeutics Market Snapshot
9.3.1. U.K. Peptide Therapeutics Market
9.3.2. Germany Peptide Therapeutics Market
9.3.3. France Peptide Therapeutics Market
9.3.4. Spain Peptide Therapeutics Market
9.3.5. Italy Peptide Therapeutics Market
9.3.6. Rest of Europe Peptide Therapeutics Market
9.4. Asia-Pacific Peptide Therapeutics Market Snapshot
9.4.1. China Peptide Therapeutics Market
9.4.2. India Peptide Therapeutics Market
9.4.3. Japan Peptide Therapeutics Market
9.4.4. Australia Peptide Therapeutics Market
9.4.5. South Korea Peptide Therapeutics Market
9.4.6. Rest of Asia Pacific Peptide Therapeutics Market
9.5. Latin America Peptide Therapeutics Market Snapshot
9.5.1. Brazil Peptide Therapeutics Market
9.5.2. Mexico Peptide Therapeutics Market
9.6. Rest of The World Peptide Therapeutics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Eli Lilly and Company
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Pfizer, Inc.
10.2.3. Amgen, Inc.
10.2.4. Takeda Pharmaceutical Company Limited
10.2.5. Teva Pharmaceuticals Industries Ltd.
10.2.6. Lonza Inc.
10.2.7. Sanofi
10.2.8. Bristol-Myers Squibb (BMS)
10.2.9. AstraZeneca PLC
10.2.10. Novartis AG
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
TABLE 1. Global Peptide Therapeutics Market, report scope
TABLE 2. Global Peptide Therapeutics Market estimates & forecasts by Region 2018-2028 (USD Million)
TABLE 3. Global Peptide Therapeutics Market estimates & forecasts by Route of Administration 2018-2028 (USD Million)
TABLE 4. Global Peptide Therapeutics Market estimates & forecasts by Type 2018-2028 (USD Million)
TABLE 5. Global Peptide Therapeutics Market estimates & forecasts by Application 2018-2028 (USD Million)
TABLE 6. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 7. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 8. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 9. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 10. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 11. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 12. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 13. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 14. Global Peptide Therapeutics Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 15. Global Peptide Therapeutics Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 16. U.S. Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 17. U.S. Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 18. U.S. Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 19. Canada Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 20. Canada Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 21. Canada Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 22. UK Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 23. UK Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 24. UK Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 25. Germany Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 26. Germany Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 27. Germany Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 28. RoE Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 29. RoE Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 30. RoE Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 31. China Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 32. China Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 33. China Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 34. India Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 35. India Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 36. India Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 37. Japan Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 38. Japan Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 39. Japan Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 40. RoAPAC Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 41. RoAPAC Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 42. RoAPAC Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 43. Brazil Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 44. Brazil Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 45. Brazil Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 46. Mexico Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 47. Mexico Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 48. Mexico Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 49. RoLA Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 50. RoLA Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 51. RoLA Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 52. Row Peptide Therapeutics Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 53. Row Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 54. Row Peptide Therapeutics Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 55. List of secondary sources, used in the study of global Peptide Therapeutics Market
TABLE 56. List of primary sources, used in the study of global Peptide Therapeutics Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
